Insights

Analysis by Julie Dautermann, Competitive Intelligence Analyst Foley is here to help you through all aspects of rethinking your long-term...

The “One Big Beautiful Bill Act,” signed into law by President Trump on July 4, 2025, will fund government efforts to continue to...

On April 17, 2025, the Centers for Medicare and Medicaid Services (CMS) announced another extension of the deadline by which skilled nursing facilities (SNFs) must revalidate their Medicare enrollments.

The U.S. Food & Drug Administration (FDA) has approved certain GLP-1 drugs for commercialization and use, including liraglutide (Victoza®), semaglutide (Ozempic®, Wegovy®), and tirzepatide (Mounjaro®, Zepbound®).

Introduction Coming on the heels of its June 2025 announcement establishing a pilot program for reactor construction and operation in...

Employers sometimes find it necessary to make the difficult decision to undergo a reduction-in-force (RIF), resulting in employee layoffs...

On November 13, Foley senior counsel Charles Gass will speak on the panel “Shaping Tomorrow: Industry Trends Through Legal, Financial, and Economic” during the Colorado Ambulatory Surgery Center Association’s (CASCA) Annual Conference & Trade Show. Gass is also CASCA’s general counsel.

Executive employment relationships are rarely permanent. When an executive or other senior-level employee terminates employment,...

The new federal budget law, the One Big Beautiful Bill Act (the Act), enacted on July 4, 2025, makes dramatic changes to the Medicaid...